DBDhwani Batra

Dhwani Batra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dhwani Batra has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Multiple lineages of monkeypox virus detected in the United States, 2021–2022

    by Crystal M. Gigante, Bette Korber, Matthew H. Seabolt, Kimberly Wilkins, Whitni Davidson, Agam K. Rao, Hui Zhao, Todd G. Smith, Christine M. Hughes, Faisal Minhaj, et al.

    Monkeypox is a viral zoonotic disease endemic in Central and West Africa. In May 2022, dozens of non-endemic countries reported hundreds of monkeypox cases, most with no epidemiological link to Africa. We identified two lineages of monkeypox virus (MPXV) among two 2021 and seven 2022 US monkeypox cases: the major 2022 outbreak variant called B.1 and a minor contemporaneously sampled variant called A.2. Analyses of mutations among these two variants revealed an extreme preference for GA-to-AA mutations indicative of human APOBEC3 cytosine deaminase activity among Clade IIb MPXV (previously West African, Nigeria) sampled since 2017. Such mutations were not enriched within other MPXV clades. These findings suggest that APOBEC3 editing may be a recurrent and a dominant driver of MPXV evolution within the current outbreak.


  • Open Access

    Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States

    by Kristine A. Lacek, Benjamin L. Rambo-Martin, Dhwani Batra, Xiao-Yu Zheng, Hitoshi Sakaguchi, Thomas Peacock, Matthew Keller, Malania M. Wilson, Mili Sheth, Morgan L. Davis, et al.

    Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.